RxDoctor Payments Data

Kristen Hibbard

Family · Baton Rouge, LANPI 1508329483

Payments from drug & device makers

$465in general payments, 2019–2025

Across 22 payments — averaging $21.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$79
  • Chiesi USA, Inc.$71
  • Regeneron Healthcare Solutions, Inc.$57
  • Mylan Specialty L.p.$46
  • United Therapeutics Corporation$41
  • Merck$34
  • plus $136 from 6 others

What the payments were for

  • Food & beverage$465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$465 in reported general payments places this provider in the 45th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$37,120
Medicare patients
195
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefdinir15$107
Ciprofloxacin Hcl13$39

Paid to pharmacies, not to this prescriber.

Other family in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →